High Energy Formula Feeding in Infants With Congenital Heart Disease
NCT ID: NCT01850784
Last Updated: 2013-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2013-02-28
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Feeding With Nutrient Dense Formula in Malnourished Infants and Children With Congenital Heart Defects
NCT04795076
Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease
NCT07115108
The Effect of High-Calorie Formula on Nutritional and Clinical Outcomes Among Infants After Congenital Heart Surgery
NCT05945459
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
NCT07087782
Comparison of Feeding Strategies for Hypoplastic Left Heart Syndrome Infants
NCT02657629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High energy formula
High energy formula (Similac)
High energy formula
The infants with CHD will be fed with high energy formula (Similac; 1kcal/ml)
Standard formula
Standard formula
Standard formula
The infants with CHD will be fed with standard formula (0.6-0.7 kcal/ml)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High energy formula
The infants with CHD will be fed with high energy formula (Similac; 1kcal/ml)
Standard formula
The infants with CHD will be fed with standard formula (0.6-0.7 kcal/ml)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* infants with CHD
* İnfants fed with formula feeding
Exclusion Criteria
* infants could not be fed enterally
8 Days
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Sami Ulus Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilek Dilli
Assoc Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dilek Dilli
Role: STUDY_DIRECTOR
Sami Ulus CH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sami Ulus CH
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nazan N Doğan, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
132/2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.